Ono Pharmaceutical Co., Ltd. (OTCMKTS:OPHLY – Get Free Report) dropped 0.9% on Thursday . The company traded as low as $3.36 and last traded at $3.42. Approximately 616,192 shares were traded during mid-day trading, a decline of 12% from the average daily volume of 700,769 shares. The stock had previously closed at $3.45.
Ono Pharmaceutical Stock Performance
The company’s 50-day moving average price is $3.63 and its two-hundred day moving average price is $4.26.
Ono Pharmaceutical Company Profile
Ono Pharmaceutical Co, Ltd., together with its subsidiaries, produces, purchases, and sells pharmaceuticals and diagnostic reagents worldwide. It offers Opdivo Intravenous Infusion and Kyprolis Intravenous Injection for malignant tumors; Emend capsules/Proemend intravenous injections for chemotherapy-induced nausea and vomiting; Demser capsules for the symptoms in patients with pheochromocytoma; and Mektovi, Velexbru, and Braftovi capsules for malignant tumors, as well as ADLUMIZ tablets for cancer cachexia.
Featured Stories
- Five stocks we like better than Ono Pharmaceutical
- How to Calculate Stock Profit
- Cerence AI: One-Hit Wonder or Long-Term Winner After NVIDIA Pact?
- Russell 2000 Index, How Investors Use it For Profitable Trading
- UnitedHealth Group Pulls Back Into Another Healthy Opportunity
- Investing In Automotive Stocks
- Micron Technology: Riding the AI Wave to Long-Term Growth
Receive News & Ratings for Ono Pharmaceutical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ono Pharmaceutical and related companies with MarketBeat.com's FREE daily email newsletter.